The results demonstrate for the first time that miR-dependent dysregulation of Atg5 takes part in the autophagy of AD and, furthermore, that miR-299-5p may potentially be beneficial to the treatment of this disease. This evidence concerns the gene ATG5 and Alzheimer disease.